Chronic non-healing skin wounds, such as leg ulcers and pressure sores, represent a major clinical problem and a financial burden for the health care systems. Chronic wounds are characterised by prolonged inflammatory phase that results in high levels of elastase, reactive oxygen species (ROS) and diminished growth factor activity. Under normal physiological conditions, elastase is a powerful host defence and its activity is regulated by endogenous inhibitors. The unrestrained elastase activity in chronic wounds may be tuned by exogenous active materials that inhibit elastase. Secretory leucocyte protease inhibitor, SLPI, is a potent endogenous inhibitor of elastase. Peptide fragments, KRCCPDTCGIKCL (Pep4) and KRMMPDTMGIKML (Pep4M), selected from SLPI primary structure were studied as potential elastase inhibitors. Kinetic studies performed for human neutrophil elastase (HNE) and porcine pancreatic elastase (PPE) in presence of these peptides revealed that both behave as uncompetitive and non-competitive inhibitors of HNE and PPE, respectively. The influence of ROS and albumin on Pep4 and Pep4M inhibitory activity towards elastase, reveals that this mixture increases the inhibitory activity of both peptides. These peptides were incorporated in hyaluronic acid hydrogels, to evaluate the possibility of being used as active compounds in a drug delivery system. Assessment of HNE and PPE activity in the presence of these hydrogels formulations revealed a considerable decrease in enzyme activity. Although, only moderated elastase inhibition was observed, these peptides represent potential candidates for chronic wound applications, as there is no need for complete elastase inhibition in the normal wound healing process.
INTRODUCTION
Wound healing is a complex biological process that ultimately results in restoration of tissue integrity 1 . This complex cascade of events starts from the moment of injury and continues for varying periods of time depending on the severity of the wounding 2 .
Physiologically, this process can be categorized in three different phases: inflammatory (consisting of the establishment of homeostasis and inflammation); proliferative (consisting of granulation, contraction and epithelialization) and remodelling (that ultimately determines the strength and appearance of the healed tissue) [2] [3] [4] [5] [6] . However, wound healing is not always a linear process and it can progress forward and backward through the different phases, depending on various intrinsic and extrinsic factors 3 .
Normal wound healing is a carefully controlled balance of destructive processes necessary to remove damaged tissue and repair processes which lead to new tissue formation 7 . Chronic non-healing wounds, such as pressure sores, diabetic foot ulcers, venous leg ulcers and other delayed wounds, have failed the progress through the normal stages of healing and therefore enter in a state of pathologic inflammation 7, 8 .
Exudates from chronic non-healing wounds contain elevated levels of proteolytic enzymes like elastase 9 , matrix metalloproteinase (MMP) 10 and plasmin 11, 12 , reactive oxygen species (ROS) 7, 9, 13 and reactive nitrogen species (RNS) 13 . The excessive production of elastase and other proteolytic enzymes by polymorphonuclear granulocytes leads to considerable reduction on the amounts of growth factors and proteinase inhibitors, resulting in an imbalance between degradation and remodelling processes 13 . In addition, the overproduction of ROS (such as, hydrogen peroxide and RNS species (like nitric oxide (NO) and its peroxynitrite derivatives) results in an imbalance oxidant/antioxidant status in chronic wounds 13 . ROS and RNS play an important role in the normal wound healing process by killing invading microorganisms and therefore their presence is necessary in the early stages of wound healing to initiate the inflammatory response 7, 13, 14 . At low concentrations (0.01-1 µM) oxidizing species such as hydrogen peroxide (H 2 O 2 ) have been shown to have a positive effect in acute wound repair, stimulating fibroblast proliferation 7 . However, their continuous presence is thought to be detrimental to the healing process 15 . Studies have shown that reactive oxygen species can induce matrix metalloproteinase production and in severe cases can result in tissue necrosis and permanent tissue damage 7, 13 . Therefore, decreasing the levels of ROS/RNS species and elastase in the wound fluid seems a suitable way to release the wound from the inflammatory phase and thus progress the normal wound healing process.
Currently, most of the dressings have been designed to create a moist wound healing environment, which allows the wound fluids and growth factors to remain in contact with wound and thus accelerating wound healing 16 . In most of the cases, these dressings are based on polymeric hydrogels, which are three-dimensional networks that swell quickly by imbibing a large amount of water. These materials closely resemble the living tissues because of their high water contents, soft and rubbery consistency and their biocompatibility to tissue and blood 16 . Hydrogels are prepared from synthetic and natural polymers. Hyaluronic acid (HA) is a naturally occurring polymer associated with various cellular processes involved in wound healing 17 . The physiological activity of hyaluronic acid (HA) polymers and oligomers makes it a promising and ideal material for wound dressing applications. HA can be tailored to a specific application but still retains its natural biocompatibility, biodegradability and lack of immunogenicity 18 .
In a previous work 19 , we have reported the application of an on-off switch, based on the reversible process of phosphorylation/dephosphorylation, to control the inhibitory activity of small peptides towards elastase, in wound dressing applications. These peptides were selected from the antimicrobial domain of an endogenous elastase inhibitor, secretory leucocyte protease inhibitor (SLPI). These tridecamer peptides, Pep4
(KRCCPDTCGIKCL) and Pep4M (KRMMPDTMGIKML), revealed differential elastase inhibitory activity for the non-phosphorylated (high inhibition) and phosphorylated (low inhibition) form. The biomatrices 20, 21 proposed to enclose this system were protease degradable materials. The biomatrix disruption was triggered by wound medium elastase, followed by active material release (inhibitor-peptides) and then in a later stage protein kinase release. The protein kinase promotes the inhibitors phosphorylation and subsequence reduction on peptides inhibitory activity towards elastase. This approach although promising required the control of several variables, such as ATP levels at wound site, peptides and protein kinase loadings and degradation rates, biomatrix degradation rate, among others.
In this article, an alternative wound dressing system is proposed. A model drug delivery system, based in hyaluronic acid hydrogels (HA), has been used to test the applicability of these 13-mer peptides, Pep4 and Pep4M, in wound dressing applications. In addition, a complete study of the kinetic parameters obtained for the substrate hydrolysis by PPE and HNE in presence of both peptides, is also reported herein. Lastly, it is evaluated the effect of the ROS, that are present in high concentrations in chronic non-healing wounds, on the inhibitory activity of the studied peptides towards PPE.
MATERIALS AND METHODS

Reagents
The inhibitor-peptides KRCCPDTCGIKCL (Pep4) and KRMMPDTMGIKML (Pep4M) All reagents were acquired with analytical grade and used as supplied. The aqueous solutions were prepared in deionized water and stored at 4ºC.
The inhibition kinetic assays were performed in microplate format, using 96 wells microplates (F96) from Nunc (Rochester, NY, US).
The ROS and HA hydrogel assays were performed in one milliliter quartz cells (108- Prior to the kinetic assays, the microplate well pathlength (l=0.82 cm) was determined using p-nitroaniline solutions ranging from 20 to 100 µM, in a total volume of 300 µL and using 8.8 mM −1 cm −1 as the molar extinction coefficient of p-nitroaniline at 410 nm [23] [24] [25] .
The microplates used in the current assays were blocked with albumin solution (BSA, 1 mg/mL) overnight, followed by three washes of thirty minutes with buffer (Tris/HCl or Phosphate buffer, pH 8.0). This pretreatment with BSA was applied to the microplates to avoid UV radiation absorption by the microplate material. and superoxide (O 2 • -)) on the inhibitor-peptides activity towards elastase was evaluated using normal physiological levels of these species (100 mM, 100 µM, 500 µM and 400 µM, respectively,) 26 . The preparation of these reactive oxygen species (ROS) was performed as described herein.
Effect of ROS on Elastase Activity -In Vitro Study
Preparation of Reactive Oxygen Species (ROS).
Hypochlorous acid was prepared immediately before use by adding diluted sulphuric acid to sodium hypochlorite till pH 6.2 is reached (Eq. 1) [27] [28] [29] . The concentration of HClO used was 100 µM, which was determined from its molar absorptivity of 100 M -1 cm -1 at 235 nm 26, 30, 31 .
Peroxynitrite was obtained as previously reported by Hughes and co-workers 32 . Briefly, 100 mL of ice-cold hydrochloric acid (0.6M)/hydrogen peroxide (0.7M) solution was poured into a stirred iced solution of sodium nitrite (0.6 M, 100mL) followed immediately by sodium hydroxide (1.5 mM, 100 mL) (Eq. 2). To increase the peroxynitrite yield in the reaction, all the solutions were mixed as fast as possible. The excess of hydrogen peroxide, used to minimize nitrite contamination, was removed from the peroxynitrite solution by adding manganese dioxide (6 mg/mL) and keeping the solution at 4ºC for 30 minutes 33 . The solution was then filtered in cellulose filters (three times) and then in nylon membrane filters with pore size of 0.2 µM (one time).
The obtained solution was then frozen at -20ºC overnight, resulting in the formation of a top yellow layer due to freeze fractionation of peroxinitrite. This yellow top layer was scraped and stored at -20ºC, for further studies. The concentration of peroxynitrite was determined by measuring its absorbance at 302 nm in 1M sodium hydroxide (Ɛ=1670
The superoxide was generated from the reaction of xanthine oxidase with xanthine 
Assessment of Elastase Activity in presence of ROS.
Prior to elastase activity assay, the inhibitors (20 µM Pep4, Pe4M and elastatinal) were incubated with each oxidant and oxidant plus albumin (50 mg/mL of BSA), in equal proportions (volumes), at room temperature, for two hours 26 27 . Afterwards, these solutions were incubated with elastase for five minutes at room temperature, immediately before initiating the enzyme activity assay.
Porcine Pancreatic Elastase activity was assayed spectrophotometrically by continuously measuring the rate of hydrolysis of the substrate N-succinyl-Ala-Ala-Ala- without oxidant treatment were performed under identical conditions. The reaction was carried out at room temperature, during 60 minutes, in a one mL quartz cell (108-000-10-40, Hellma, Müllheim, DE) and monitored at 410 nm using an UV-Vis Shimadzu spectrophotometer (UV-2501PC, Kyoto, JP).
Study of the Reaction BSA-H 2 O 2 by Electrophoresis (SDS-PAGE). SDS-PAGE
electrophoresis was used to follow the reaction between albumin (BSA) and hydrogen peroxide (H 2 O 2 ) and this assay was performed as described by Laemmli 43 . This 
Elastase Activity Assay in the presence of HA Hydrogel Formulations
Hydrogel Preparation. The hydrogel crosslinking procedure used herein has been previously outlined by J. W. Burns and co-workers 44 . Briefly, in order to obtain an autocrosslinked hyalorinic acid (HA) hydrogel 45 , 100 mg of HA was dissolved in 10 mL of deionized water. The pH of the aqueous solution was adjusted to 4.7, using HCl 1M and then casted into 35 mm diameter petri dishes (83.1800.002, Sarstedt, DE).
Subsequently, the petri dishes were frozen at -20ºC for 2.5 days and then thawed at 25ºC. Afterwards, the hydrogels were dehydrated in an incubator shaker (Infors HTMinitron, Bottmingen, CH) at 35ºC during approximately 10 hours. Then the thickness of the obtained films ( Figure 1 ) was determined using a digital micrometer (series 293, Mitutoyo, Kanagawa, JP).
Water Content and Thickness of HA Hydrogels. To determine the water content, the dehydrated HA hydrogels were weighed and then incubated in 4 mL of deionized water for 30 minutes. The water excess was removed and the hydrogels re-weighed. The water content of the hydrogels was calculated according to equation 3
where, Wh represents the weight of the hydrated hydrogel and Wd the weight of the dried film. The thickness of the HA films was determined using a digital micrometer HA hydrogels were also hydrated with 2 mL of 200 µM phosphate buffer, pH 8.0, to use as control in the elastase enzymatic assay. These hydrogels, with a final pH of 8.0, were allowed to incubate for 30 minutes at room temperature.
PPE and HNE activity was assayed spectrophotometrically using N-succinyl-Ala-AlaAla-p-nitroanilide and MeOSuccynyl-Ala-Ala-Pro-Val-p-nitroanilide as respective substrates. Briefly, the HA hydrated hydrogels (described in this section) were incubated in 1mL of elastase solution (36 munits/mL of PPE and HNE) 46 for 1 hour at room temperature [46] [47] [48] [49] spectrophotometric measurement of the release of p-nitroaniline from the enzymatic hydrolysis of the substrates was performed at 410 nm in a Shimadzu spectrophotometer (UV-2501PC, Kyoto, Japan) using one mL quartz cuvettes (Hellma, Müllheim, DE).
RESULTS AND DISCUSSION
The tridecamer peptide Pep4 primary structure, KRCCPDTCGIKCL (Figure 2 ), was selected from the natural human neutrophil elastase (HNE) inhibitor, secretory leucocyte protease inhibitor (SLPI). This peptide structure was picked from the inner part of an extended planar spiral in the N-terminal domain of SLPI 50 . Due to the high cysteine content of this tridecamer peptide, a mutation of this peptide was also designed having replaced the cysteine residues for a less reactive residue, methionine, and therefore generating a second 13-mer peptide Pep4M, KRMMPDTMGIKML.
Elastase Inhibitor Kinetic Assays
Enzymatic kinetics of PPE and HNE were studied in the presence of the inhibitorpeptides (Pep4 and Pep4M) and elastatinal (non-peptidic elastase inhibitor used as control) [51] [52] [53] . Kinetic data shown in Michaelis-Menten plots for Pep4 ( and the resulting kinetic parameters, ! !"" and !"# !"" (see Table I ). However, there is a general tendency within the obtained values of ! !"" and !"# !"" for the different inhibitor concentrations relatively to the K m and V max values (Table I) . For PPE, ! !"" remain constant and !"# !"" decreases comparatively to V max , while for HNE, ! !"" and !"# parameters. This hypothesis was tested performing a kinetic assay of PPE inhibition by Pep4 (8 µM) in presence and absence of a reducing agent (DL-Dithiothreitol, 1-5 mM).
However, the Michaelis-Menten plot revealed no significant differences between Pep4
and Pep4+DTT hyperbolic curves (data not shown). Consequently, no alteration of the kinetic parameters, ! !"" and !"# !"" , were observed when Pep4 with and without DTT were used as elastase inhibitor (Figure 4) . A mutated peptide (Pep4M) where the cysteine residues were replaced by the methionine residues was also used to eliminate the possibility of occurring disulfide bridges intra and inter-residues, which might alter the behaviour of the peptide in solution. Kinetic assays using Pep4M as inhibitor and PPE and HNE as enzyme have been performed ( Figure 5 and Table II Table III .
PPE inhibition by Pep4 and Pep4M was analysed considering that elastase and the inhibitor-peptides follow a mixed inhibition mechanism, described in Figure 6 b). The analysis of direct linear plots (Figure 3 and 5) and the kinetic parameters resumed in Table I and II, for PPE inhibition by Pep4 and Pep4M, reveal that ! !"" remain constant and !"# !"" decreases comparatively to V max and that alpha/alpha' (α/α') ratio is approximately one. Thus, PPE inhibition by both inhibitors-peptides is a particular case of the mixed inhibition, the non-competitive inhibition. In this inhibition type, the inhibition constants, K ic , and K iu are similar and consequently K m is equal to ! !"" . The inhibitions constants were determined from equation 5 and the respective values comprised in Table I and II.
The inhibition constants, K ic and K iu , increased with the inhibitor concentration, which it is not expected to occur. The inhibition kinetics of HNE by Pep4 and Pep4M was evaluated considering that enzyme and inhibitors follow an uncompetitive inhibition.
According to the direct linear plots (Figure 3 b) and d) and Figure 5 b ) and c)) and to the kinetic parameters included in Table I and II, for HNE inhibition by Pep4 and Pep4M, it is possible to state that ! !"" and !"# !"" decrease comparatively to K m and V max , respectively. The ratio
!"" is constant for all inhibitor concentrations and identical to
. For this inhibition type, the inhibition constant, K iu , was determined using equation 5 and the obtained values were included in Table I and II.
The inhibition constant, K iu , increase with the inhibitor concentration and as previously emphasized this situation might be due to the absence of a direct relation between the inhibitor concentration applied and the levels of elastase inhibition achieved. Therefore, to better elucidate the behaviour of both peptides as elastase (PPE and HNE) inhibitors, a plot comprising the V max /K m ratio versus the inhibitor concentration was drawn ( Figure 7 ). In this plot, for all the enzyme and peptide combinations the obtained result was nearly a horizontal straight line. In the HNE assays, this was the expected behaviour once in the uncompetitive inhibition the ratio V max /K m should remain unchanged for all the inhibitor concentrations. In opposition, in the PPE assays a decreasing line was expected, once in the mixed inhibition type the ratio V max /K m might decrease with the inhibitor concentration.
In a previous work we have reported that Pep4 and Pep4M behave as slow velocity substrates of elastase (PPE) that at low concentrations function as elastase inhibitors 19 .
Even so, comparing the inhibition constant, K ic , for PPE in presence of Pep4 (0.46-5.00 µM), Pep4M (0.54-1.67 µM) and elastatinal (5.2±2.9 and 5.8±1.8 µM), it is thus possible to state that at lower inhibitor-peptide concentrations (lower than 8 µM)
comparable values of K ic can be achieved for these inhibitor-peptides relatively to elastatinal. Moreover, according to these studies Pep 4 and Pep4M behaved as mixed PPE inhibitors, which mean that both peptides bind to the free enzyme (E) to give an EI complex or to the enzyme-substrate complex (ES) to give a complex ESI 55 . In this particular case, as the α/α' ratio is approximately one, these inhibitors bind in equal proportion both to the free enzyme and to the enzyme-substrate complex. However, these peptides behaved as uncompetitive HNE inhibitors, which means that these inhibitors only bind to the enzyme-substrate complex (ES) and do not to bind to the free enzyme (E). The current study revealed that for these elastase inhibitor-peptides, Pep 4
and Pep4M, the PPE does not seems an appropriate enzymatic model for HNE, once no similar behaviour was observed for both enzymes in presence of these peptides.
ROS Effect on Elastase Activity
In humans, the endogenous antiproteases are known to be inactivated from stimulated neutrophils 26 . For instance, alpha- 59 .
Huang and co-workers 26 have reported a family of trifluoromethyl ketone elastase inhibitors, which resist superoxide, hypochlorous acid, hydrogen peroxide, hydroxyl radical and peroxinitrite mediated degradation. They have determined the stability of each inhibitor in the presence of superoxide, hypochlorous acid, hydrogen peroxide, hydroxyl radical and peroxinitrite, performing an incubation of two hours at 37ºC and then measuring the elastase activity, for one hour, in presence of the inhibitor-oxidant mixture. Wasil and co-works 27 have performed a similar study but they have added albumin to the inhibitor-oxidant mixture, which reveal to have a striking protective effect on the inhibitor. Both studies seemed relevant and of major importance, thus we have extended these studies to our current work. Therefore, Pep4, Pep4M and elastatinal (20 µM) were incubated with hydrogen peroxide (H 2 O 2 , 100 mM), hypochlorous acid (HClO, 100 µM), peroxinitrite (ONOO -, 500 µM) and superoxide (O 2 • -, 400 µM) and elastase (PPE) activity measured ( Figure 8 ). The inhibitors concentration tested in this assay does not correspond to the concentration that mostly inhibits PPE. It has been used the same concentration for all inhibitors in order to establish a comparative study.
In Figure 8 27 , in which was reported that the presence of albumin, in concentrations lower than physiological concentrations, was able to completely inhibit inactivation of α1-PI by HClO.
Presumably, albumin reacts with HClO and preferentially scavenges this radical.
Therefore, albumin reveals substantial antioxidant activity by scavenging HClO 27 .
In Figure 8 from ROS inactivation but also increases its inhibitory activity.
The same study was performed for Pep4 (Figure 8 a) oxidants. In the case of radical HClO, the presence of albumin decreased slightly the inhibitory activity of Pep4.
A possible explanation for these results might stand in the structural differences between these two inhibitor-peptides, Pep4 and Pep4M. Pep4M comprise four methionine residues, while Pep4 contains four cysteine residues that provide exposed free sulfhydryl groups (SH) that are very reactive and potential targets for radical attack.
With respect to proteins, the thiol group of cysteinyl side chains is susceptible to a number of oxidative modifications, for instance, the formation of inter-or intramolecular disulfides between protein thiols (protein (P)-S-S-P) or between protein thiols and low-molecular-weight thiols such as glutathione (P-S-SG), the oxidation to sulfenic (P-SOH), sulfinic (P-SO 2 H), and sulfonic (P-SO 3 H) acid and S-nitrosylation (P-S-NO). These modifications can alter the function of numerous proteins that contain cysteines of structural importance, within their catalytic centers or as part of proteinprotein interaction interfaces [67] [68] [69] [70] .
Thus, the H 2 O 2 (or other ROS) attack to the thiol side chain (-SH) of cysteine residues in Pep4, might involve the formation of dissulphide bridges (S-S) or the -SH groups might be oxidized to sulphenic acid (-SOH) and this can be further oxidized to sulphinic acid (-SO 2 H) or sulphonic acid (-SO 3 H) 69 . This structural modification might contribute to the increase of Pep4 inhibitory activity towards elastase comparatively to Pep4M, in this study.
In addition, to better understand the albumin (BSA) effect on the system elastaseinhibitor-peptide-ROS, some alterations have been introduced into the previous assay.
The elastase enzymatic assay was performed in presence of Pep4M, Pep4M+H 2 O 2 , Analysing these gels it was possible to state that no difference has been observed between the oxidant mixture BSA+H 2 O 2 incubated for two or twenty-two hours and the correspondent control of BSA. Moreover, it was performed another assay using a 10%
resolving gel instead of 8% and using the lowest BSA and H 2 O 2 concentrations in the oxidant mixture ( Figure 11 ). With this assay we intent to visualize whether some low molecular degradation products were formed during the incubation period of BSA with H 2 O 2 . As in the previous gel, no differences were observed between the BSA samples and the respective oxidant mixtures. Therefore, no experimental explanation has been found for the fact that the presence of BSA enhances the inhibitory activity of the selected inhibitor-peptides. We envisage that the inhibitory capacity of the studied peptides, Pep4 and Pep4M, might be enhance when in close contact with chronic wound exudate, due to the presence of albumin in wound medium. Moreover, the peptide concentrations tested in this assay (20 µM) is far from being the optimal concentration for each peptide to inhibit elastase. Thus, improved results are expected if 1 µM of Pep4 or 4 µM Pep4M 19 were used, instead of 20 µM. Therefore, this study demonstrates that the selected peptides are optimal candidates to be applied in wound dressing applications.
Elastase Activity in presence of HA Hydrogel Formulations
Hyaluronic acid is a naturally occurring polymer, non-immunogenic, non-adhesive glycosaminoglycan that plays a prominent role in various wound-healing processes, such as angiogenesis 71 . Hyaluronic acid promotes early inflammation, which is critical for initiating wound healing, but then moderates later stages of this process, allowing matrix stabilization and reduction of long-term inflammation 71 . Furthermore, environments around human tissues involved in regeneration and wound healing are enriched with HA 71 . This cumulative evidence suggests that HA is an ideal candidate material for modulating wound healing. Therefore, HA hydrogels were used herein as wound dressings to enclose the inhibitors Pep4, Pep4M and elastatinal and further assayed their inhibitory capacity towards elastase (PPE and HNE). The Pep4, Pep4M
and elastatinal concentrations used in the PPE assay were 1, 4 and 64 µM, while in the HNE assay were 32, 1 and 64 µM, respectively. These concentrations correspond to the inhibitor concentrations that highly contribute to the decrease on elastase activity. To assess the ability of the HA-inhibitor (Pep4, Pep4M and elastatinal) hydrogels to lower elastase activity, HA hydrogels with and without inhibitor were placed in a solution of elastase at physiological levels (36 mUnits/mL of elastase in chronic wounds) 46 . The elastase activity present in the solution removed from the HA-inhibitor hydrogels were then compared with the activity of the solution from the HA without inhibitor ( Figure   12 ). All HA hydrogel formulations containing inhibitor (Pep4, Pep4M or elastatinal)
were found to inhibit elastase (PPE and HNE) activity. In the PPE assays, Pep4 and Pep4M induced an elastase activity decrease of 34.6 and 37.1%, respectively. In the HNE assay, these peptides promoted a more considerable reduction on elastase activity, 67.9% for Pep4 and 72.5% for Pep4M. Elastatinal achieves, in both assays, the higher elastase inhibition, with inhibition levels of 97.6 and 83.1% in the PPE and HNE assay,
respectively. In the current study is shown a pattern, for both assays (PPE and HNE) the elastase inhibitory capacity obeys to an order: Pep4<Pep4M<Elastatinal.
The HA films prepared for this assays were characterized in terms of water content and thickness. The water content of the HA hydrogels was determine as previously described, using equation 3. The water content average for the prepared HA hydrogels was 97.86±0.09%. The thickness of the HA films was determined using a micrometer and the average thickness of the prepared films was 29±4 µm. Hyaluronic acid (HA) or hyaluron has gained much attention due to its prominent role in wound healing as well as its natural biodegradability. HA based hydrogels are designated by some authors as biomaterials that heal, because these biomimetic materials are designed to promote natural healing and regeneration 17 . Thus, the HA hydrogels were chosen as our based material to incorporate the inhibitor-peptides and the resulting formulations evaluated as potential drug delivery system. These biomimetic materials were assessed in presence of HNE and PPE, at physiological concentrations (36 mUnits/mL of protease in chronic wounds) 46 and these formulations have induced a significant decrease in the elastase activity.
According to Wiegand and co-workers, elastase concentration was found to be 10-times higher in chronic than in acute wound fluids (2,480.01 ng/mg and 245.85 ng/mg, respectively) 72 . These finds emphasized the fact that no complete elastase inhibition is needed for the wound healing progress. Therefore, the inhibitor-peptides reported herein that have revealed moderated elastase inhibition, represent potential candidates for wound dressing applications. The incorporation of these inhibitor-peptides (Pep4 and Pep4M) at very low concentrations (less cost) in HA hydrogel films, which promote natural wound healing and regeneration, might be taken in consideration for future therapeutic applications. 
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FIGURES FIGURE 1
Image of a hyaluronic acid (HA) hydrogel film. HA hydrogel films were prepared by autocrosslinking as previously reported by Burns and co-workers 44 . and HNE assay, respectively). The current assays were performed in triplicate.
FIGURE 6
Schematic representation of the models for competitive inhibition a) and mixed inhibition b). Adapted from the reference 55 . 
FIGURE 11
Visualization of potential reaction products from the reaction albumin + hydrogen peroxide by SDS-PAGE. Electrophorese gels were prepared using 4% stacking gels and 10% resolving gels. Gel revelation was performed with Coomassie blue. 
